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Abstract
Purpose: The present study addressed two questions related to macronutrient supplementation
during endurance exercise. Firstly, the effects of carbohydrate and protein co-ingestion on time
trial (TT) performance were compared to carbohydrate alone. Secondly, the effects of isolated
protein ingestion on TT performance were compared to a placebo.
Methods: Six trained cyclists (Age: 22 ± 1 years; Height: 167 ± 12 cm; Weight: 60 ± 10 kg;
VO2max: 62 ± 7 ml/kg/min) completed four experimental trials, consisting of constant-load cycling
for two hours (55% Wmax) immediately followed by a 30-km simulated time trial. During the trials,
subjects consumed one of four experimental beverages at regular intervals during exercise: a noncaloric placebo (PL), a protein-only beverage (PR: 15 g/hr), a carbohydrate-only beverage (45
g/hr), or a carbohydrate and protein beverage (CP: 45 g/hr CHO + 15 g/hr PRO). Physiological
measurements (VO2, VE, HR, RER, blood glucose, and blood lactate) and subjective
measurements (GI distress and RPE) were assessed throughout both the constant-load and TT
exercise phases. Trials were completed in a randomly-counterbalanced order. Mean ± 90%
confidence intervals were calculated for all measures, and magnitude-based qualitative inferences
were used to assess treatment effects.
Results: In comparison to PL (62.8 ± 8.1 min), both CHO and CP provided ‘possible’ benefits in
TT performance (58.9 ± 6.5 min; 59.2 ± 9.4 min respectively) while no clear effects of PRO on
performance were observed (61.0 ± 8.0 min). Furthermore, CP had no clear effect on performance
versus CHO.
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Conclusions: In our sample, the addition of protein to a moderate-dose of carbohydrate did not
result in meaningful improvements in time trial performance versus carbohydrate alone. Similarly,
protein consumption alone provided no ergogenic effects versus a placebo.
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Chapter I: Introduction
In the world of competitive sports, the smallest improvements in performance can make
the difference between making a team or being cut; making a diving catch or coming up short, or
even the difference between winning and losing a championship. Nutrition has long been a
variable that athletes manipulate in an effort to maximize performance. For example, numerous
studies have reported that carbohydrate ingestion during exercise improves endurance
performance through mechanisms relating to overall energy supply and manipulation of the
central nervous system (15). It has been found that blood glucose is a key source of energy
during prolonged exercise (15). With the intake of supplemental carbohydrates, liver and muscle
glycogen stores may be spared, and high rates of carbohydrate oxidation can be maintained for
longer durations during exercise (15). Additionally, supplemental carbohydrate ingestion during
exercise has been found to provide benefits via the central nervous system, and rinsing the mouth
with carbohydrate solutions (even without ingestion) may also, improve endurance performance
(15).
The concept of supplementing carbohydrates and fluids during exercise began in 1965 at
the University of Florida in an attempt to improve the Gator’s on-field performance (5). It was
discovered that providing the athletes with a solution rich in carbohydrates and electrolytes
helped the athletes perform at a higher level (5). The beneficial effects of carbohydrate sports
beverages on metabolism and performance is strongly supported in the scientific studies from the
past 35 years (5). As a result, carbohydrate-electrolyte sports beverages are used ubiquitously
among modern endurance athletes.
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More recently, the potential ergogenic effects of supplemental protein in sports beverages
has been investigated. In 2003, Ivy and colleagues reported that the co-ingestion of carbohydrate
and protein (CHO+P) during exercise significantly prolonged time to fatigue during cycling
exercise versus a carbohydrate-only beverage (9). Saunders and colleagues reported similar
findings in a study conducted in 2004 (14). These initial studies indicated that the addition of
protein to a carbohydrate supplement provided additional performance benefits over
carbohydrates alone. However, the generalizability of these findings were limited by two issues.
Firstly, both studies used Time-to-Exhaustion (TTE) exercise protocols which required subjects
to cycle at a specified intensity, for as long as possible. Although an important outcome,
improvements in TTE are not directly applicable to athletic performance, as cycling events are
generally performed with the goal of completing a fixed distance in the fastest time possible. A
second limitation of the aforementioned studies relates to the concentrations of carbohydrate
(CHO) and protein (PRO) in the experimental beverages. Both studies compared CHO+P
beverages versus CHO beverages that were matched for carbohydrate content. As a result, the
CHO+P beverages contained additional calories, and it could not be determined if the observed
improvements in performance were due to a unique benefit from protein per se.
Numerous studies have subsequently been conducted to determine the effects of CHO+P
beverages on endurance performance. The topic remains controversial, and generalizations are
difficult due to the wide variety of exercise protocols and beverage comparisons among these
studies. However, beverage composition has an important influence on performance outcomes,
and a better understanding of the literature can be obtained by examining the existing studies
based on the type of experimental beverages examined in each study, as discussed below.
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One group of CHO+P studies have used experimental beverages that were matched for
carbohydrate content, with total carbohydrate intake below maximal gastrointestinal uptake rates
(and, thus, below the rates theorized to produce optimal ergogenic effects with carbohydrates).
Specifically, all studies in this group used experimental beverages ingested at rates below 50
gCHO•hr-1. In 2003, in a study by Ivy, three experimental beverages were used in a time-toexhaustion exercise protocol (9). Experimental beverages consisted of placebo, a 7.75%
carbohydrate solution (CHO), and a 7.75% carbohydrate + 1.94% protein solution (CHO+P).
The researchers observed that the addition of protein to the carbohydrate supplement improved
time-to-exhaustion versus the placebo and CHO beverages (9). In 2004, Saunders and colleagues
compared the effects of a 7.3% carbohydrate solution (CHO) versus a 7.3% carbohydrate and
1.8% protein solution (CHO+P) (14). Similar to Ivy, the study by Saunders found that subjects
consuming the CHO+P beverage exercised 29% longer at 75% VO2peak than those consuming the
CHO beverage (14). Finally, in 2007, another study by Saunders used gels matched for
carbohydrate content below the maximum absorption rate (16). The experimental gels consisted
of a 0.15 g carbohydrate per kg of bodyweight solution (CHO) and a 0.15 g carbohydrate per kg
of bodyweight + 0.038 g protein per kg bodyweight solution (CHO+P) (16). It was found that
those subjects consuming the CHO+P gel rode 13% longer at 75% VO2peak on a cycle ergometer
than those that consumed the CHO gel (16). Based on these studies it appears that the addition of
protein to carbohydrate sports beverages can elicit significant improvements in TTE versus CHO
beverages, when the carbohydrate content of the beverages is below the maximal absorption rate.
However, no published studies to date have compared the effects of carbohydrate-matched
beverages on time trial performance, so the effects of CHO+P on endurance ‘performance’ under
these conditions cannot be quantified.
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Following the publication of the aforementioned studies by Ivy and Saunders, subsequent
studies examined whether the addition of protein could enhance the efficacy of carbohydrate
beverages consumed at maximal gastrointestinal uptake rates (i.e. at rates believed to optimize
the ergogenic effects of CHO intake). Specifically, the studies in this group used experimental
beverages that containing greater than 60 gCHO•hr-1. In 2009, a study by Saunders used
experimental beverages consisting of 6% carbohydrates (CHO) and 6% carbohydrates and 1.8
grams of protein hydrolysate (CHO+P) (17). It was found that late-exercise time trial
performance was enhanced by a small, but significant, degree (~30 s over the final 5 km) with
consumption of the CHO+P beverage compared to consumption of the CHO beverage (17). In
contrast, other studies in this group observed no beneficial effects of supplemental protein. For
example, Van Essen and colleagues (2006) used experimental beverages with 6% carbohydrates
(CHO), with an additional 2% protein (in the CHO+P beverage) (21). Van Essen observed no
differences in performance between beverages (21). In 2010, Breen and colleagues used similar
beverages with a time-trial exercise protocol. Experimental beverages consisted of 65 gCHO•hr1 (CHO) plus an additional 19 gPRO•hr-1 (CHO+P) (1). Breen found that the CHO+P beverage
did not improve late-exercise performance versus the CHO beverage (1). Lastly, in 2008, a study
by Valentine compared two different carbohydrate-only beverages in addition to a carbohydrate
plus protein beverage (20). Experimental beverages consisted of a placebo (PLA), a 7.75%
carbohydrate solution (CHO), a 9.69% carbohydrate solution (CHO+CHO), and a 7.75%
carbohydrate solution with an additional 1.94% protein solution (CHO+P) (20). In this study,
CHO and CHO+P were matched for carbohydrate content while CHO+CHO and CHO+P are
matched for caloric content. No significant differences in time-to-exhaustion were observed
between CHO+P, CHO or CHO+CHO beverages, although all three experimental beverages
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improved performance over the placebo (20). This group of studies has collectively shown that
adding protein to carbohydrate beverages consumed at maximal gastrointestinal absorption rates
of carbohydrates, appears to have little to no effect on improving endurance performance.
Researchers have also examined whether CHO+P beverages influence performance
versus carbohydrate beverages that are matched for total calories. In 2006, Romano-Ely and
colleagues used experimental beverages with 9.3% carbohydrates (CHO) and another with 7.5%
carbohydrates with an additional 1.9% protein (CHO+P) (13). Subjects cycled at 70% VO2peak
until fatigue under each experimental condition. No differences in TTE were observed between
CHO and CHO+P (13). In 2008, Valentine and colleagues found similar results during a study in
which two different carbohydrate-only beverages were compared in addition to a carbohydrate
plus protein beverages (as previously discussed) (20). The results of Valentine’s study have
indicated that the isocaloric beverages, CHO+CHO and CHO+P were not significantly different
in time to exhaustion at the 75% VO2peak intensity (20). Together, the studies by Romano-Ely
and Valentine have indicated that CHO+P beverages do not improve endurance performance
versus carbohydrate beverages matched for total calories. However, these studies also
demonstrate that some carbohydrates can be replaced with protein without adversely affecting
endurance performance.
A final group of studies has used beverages not matched for carbohydrate content or
calories. These studies are harder to interpret, as potential differences in performance between
treatments cannot be attributed to differences in individual macronutrients and/or calories.
Nevertheless, McCleave and colleagues (2011) investigated the effects of a CHO+P beverage
containing 3% carbohydrates and 1.2% protein, versus a CHO beverage containing 6%
carbohydrates (11). Subjects completed a protocol consisting of 3 hours of varied-intensity
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cycling following immediately by a ride to exhaustion at ~75% VO2max. TTE was significantly
greater with consumption of CHO+P compared to CHO (20). In 2010, a study by MartinezLagunas and colleagues used three beverages, none of which were matched for carbohydrate or
caloric content (10). Beverage CHO+PRO H contained 4.5% carbohydrates and 1.15% protein,
beverage CHO+PRO L contained 3% carbohydrates and 0.75% protein, and beverage CHO
contained 6% carbohydrates. Subjects cycled at intensities between 55% and 75% VO2max for 2.5
hours before completing a ride at 80% VO2max until fatigue. No significant differences in TTE
were found between CHO, CHO+PRO H, or CHO+PRO L (10). Similar to the aforementioned
findings from McCleave and colleagues, Martinez-Lagunas showed that a beverage (CHO+PRO
L) lacking in carbohydrate content, protein content, and total calories was able to elicit similar to
results to the beverages containing more macronutrients. A final study, by Schroer and
colleagues (2014), examined the effects of protein intake (without carbohydrate co-ingestion) on
performance. The study compared three different treatment beverages: a placebo (PLA), a
beverage containing 45 g/L protein (PRO), and a beverage containing 15 g/L alanine an amino
acid present in protein, which has been speculated to have possible influences on performance
(18). Subjects performed 120 minutes of cycling at 55% Wmax before completing a 30 km time
trial. Both ALA and PRO beverages ‘possibly’ harmed time trial performance compared to PLA
(18). The results of this study (as well as those from the aforementioned investigations in this
section) suggest that the previously published improvements in performance with CHO+P coingestion are not the simple result of additional calories from protein. Instead, it is possible that
protein may be impacting endurance performance via another mechanism, such as a proteinspecific synergistic influence on the ingested carbohydrate. However, it should be noted that the
protein intake rates in the Schroer study (45 g/hr whole protein) greatly exceeded the amounts of
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protein co-ingested with CHO in studies that have reported performance benefits with CHO+P
(typically 10-20 g/hr), which likely contributed to the possible detriments in performance versus
CHO. It is not currently known whether protein ingestion at these lower rates has any impact on
endurance performance.
In summary, at least three studies have reported that CHO+P ingestion at moderate intake
rates (< 50 gCHO/hr) results in substantial improvements (13-36%) in TTE versus CHO
beverages containing equal carbohydrate content (9, 14, 16). Additional calories in the CHO+P
beverages of these studies (due to the supplemental protein) have been cited as a criticism of
these investigations. However, there is no evidence to date that the ingestion of protein alone has
any impact on endurance performance and one recent study reported that relatively high protein
intake during exercise may actually impair performance. Thus, it is possible that CHO+P
ingestion may be impacting endurance performance via another mechanism, such as a proteinspecific synergistic influence on the ingested carbohydrate.
A number of studies have reported that CHO+P ingestion has no influence on endurance
performance in cycling time trials (1, 12, 21), which represent athletic performance more closely
than TTE protocols. However, each of these studies utilized beverages consumed at very high
rates of CHO ingestion (> 60 gCHO/hr), in which additional macronutrient intake has little or no
impact on performance. As a result, it remains unknown whether CHO+P ingestion at moderate
intake rates (< 50 gCHO/hr) results in meaningful improvements in cycling performance, in
addition to TTE.
As illustrated above, there are numerous unanswered questions regarding the influences
of CHO+P ingestion on endurance performance. Specifically, it remains to be determined how
varying amounts of carbohydrate and protein intake (alone, and co-ingested) influence
15

performance during prolonged cycling time trials. Our laboratory is currently conducting a study
investigating two questions on this topic:
1) Does CHO+P ingestion (at 45 gCHO/hr + 15 gPRO/hr) improve cycling performance
versus a CHO beverage matched for carbohydrate content (45 gCHO/hr)?
2) Does the ingestion of 15g/hr of protein ingestion improve cycling performance versus
a placebo (PL)?
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Chapter II: Methodology
Participants
Study participants were recruited and selected based on three primary criteria. First, all
subjects were required to be between 18 and 45 years of age. Secondly, each subject, following
their VO2peak measurement, was required to have a VO2peak greater than 55 ml/kg/min or 4.5
L/min. Finally, each selected subject was characterized as “low risk” for exercise complications
using criteria from the American College of Sports Medicine’s Guidelines for Exercise Testing
and Prescription (9th Ed., ACSM, 2014).
Twelve subjects were recruited for the current study and based on their completion of the
criteria mentioned previously. Of the twelve recruited subjects, five (3 males and 2 females)
completed all experimental trials while the final subject completed only three experimental trials
(Age: 22 ± 1 years; Height: 167 ± 12 cm; Weight: 60 ± 10 kg; VO2max: 62 ± 7 ml/kg/min).
Study Design
Selected subjects completed a total of six trials, each of which being separated by 5-7
days. Specifically, the following trials were completed: 1 pre-testing trial, 1 familiarization trial,
and 4 trials containing experimental treatments. With each experimental trial, subjects consumed
one of the following four beverages. Subject either received a non-caloric placebo (PLA), a
protein-only beverage (15 g/hr – PRO - whey), a carbohydrate-only beverage (45 g/hr – CHO dextrose), or a combination of carbohydrate and protein (45 g/hr CHO + 15 g/hr PRO – CP), all
of which were matched for flavor.
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Experimental Trial Design
Subjects completed four experimental trials using an electronically braked cycle
ergometer. Two exercise phases were completed within each trial. The first phase consisted of
120 minutes of steady-state cycling at 55% Wmax. The second phase of the exercise protocol
consisted of a simulated 30-km time trial (~50 minutes).
Experimental Treatments
Treatments were supplied to subjects using a randomly counterbalanced, double-blinded,
placebo design. Beverages were provided to subjects before the exercise protocol began,
throughout the steady-state exercise phase, and throughout the time trial. Prior to exercise,
subjects received a bolus dose (600 ml) of their specific beverage. During the steady-state
exercise phase, subjects received 150 ml every 15 minutes. Finally, during the time trial, subjects
received 150 ml at three specific distance points, those being 7.5 km, 15 km, and 22.5 km. Each
beverage was consumed within two minutes during exercise.
Dietary and Exercise Controls
Subjects were given a “food log” to record all dietary intake 24 hours prior to their first
experimental trial. The subject was told to replicate this dietary intake prior to each experimental
trial thereafter. Dietary logs were then obtained following each experimental trial.
Subjects were told to refrain from any form of heavy exercise 48 hours prior to each
experimental trial. Additionally, subjects were asked to record all physical activity 72 hours
preceding each experimental trial. All subjects were asked to continue exercise habits throughout
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the duration of the study with consideration towards the final 48 hours prior to each experimental
trial.
Subjects performed each experimental trial being fed prior to the initiation of exercise.
Standardized meals were given to each subject 1-2 days prior to each trial. The night before each
trial, subjects consumed a liquid meal replacement (Ensure Shakes). Two hours prior to the
experimental trials, subjects then consumed a standardized meal of ~500 kcals.
Measurements
Performance Time and Mean Power Output: were used to measure exercise performance,
measured during phase 2.
Metabolic Measurements: A Moxus Modular Metabolic System recorded metabolic
measurements at the following times during exercise: minutes 15, 35, 55, 75, 95, and 115 of
phase 1, and at 20 km and 30 km of phase 2.
Blood Glucose and Lactic Acid: finger stick blood samples were obtained at the following times:
minutes 20, 40, 60, 80, 100, and 120 of phase 1, and at 20 km and 30 km of phase 2. Glucose and
lactate levels was determined using an automated analyzer.
Heart Rate: was assessed at the same times as blood glucose and lactic acid using a heart rate
monitor. Average heart rate of the 30 km time trial was also recorded.
Ratings of Perceived Exertion (RPE): subjective ratings of exertion was collected using a Borg
RPE scale measured 6-20. Measurements were obtained at the times mentioned for blood
glucose and lactic acid.
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Gastrointestinal Distress Scale: subjects were asked to complete a questionnaire at minutes 30,
60, 90, and 120 of phase 1, and at 20 km and 30 km of phase 2. The questionnaire contains
questions regarding the presence of the following GI problems: stomach problems, GI cramping,
bloated feeling, diarrhea, nausea, dizziness, headache, belching, vomiting, and urge to urinate or
defecate. The items were then scored on a 10-point scale (1 = not at all, 10 = very, very much).
Data Analysis
Probabilistic magnitude-based inferences, using methods described by Hopkins and
colleagues, were used to analyze collected data for the present study (7). Many recently
published studies have utilized this method of analysis, especially those investigating the effects
of nutritional supplementation on endurance performance. This approach has several advantages
over null-hypothesis testing as the Hopkins method uses effect-magnitudes, estimate precision,
and interpretive descriptors in order to qualify the probability of an important experimental
effect. The present study maintained a 90% confidence interval to illustrate uncertainty within
treatment effects, as this confidence interval represents an ‘unclear’ effect with a >5% chance of
being either negative or positive (7). Additionally, threshold values indicating a substantial
change were calculated as 0.2 x SD (Standard Deviation), from the placebo trial. A spreadsheet
(6), developed by Hopkins and colleagues was utilized in order to classify treatment effects as
either beneficial (positive), harmful (negative), or trivial (negligible) (5). The following
qualitative inferences were used to describe the likelihoods of reaching substantial change
threshold values: <1%: most unlikely, 1-5%: very unlikely, 5-25%: unlikely, 25-75%: possible,
75-95%: likely, 95-99%: very likely, and >99%: most likely. An ‘unclear’ inference was applied
to measurements that contained values within the 90% CI that exceeded threshold for both
positive and negative effects.
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Chapter III: Results
30-km Time Trial Performance
Mean performance times, power outputs, and qualitative inferences for comparisons between
treatments are summarized in Figure 1, Figure 2, and Figure 3. Most notably, both CHO and
CHO+PRO were shown to have ‘possible benefits’ over PL (-3.9 ± 5.0% and -3.6 ± 5.4%
respectively). No clear effects were observed between other treatments.

Finishing Time (minutes)

75
70
65
60
55
50
45
40
PL

CHO
PRO
Treatment

CP

Figure 1. Mean time trial performance measurements (in minutes) for each experimental
beverage. Y-axis error bars represent one standard deviation of the mean.
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Physiological Measurements during Constant-Load Cycling
Measured values of VO2, RER, blood glucose and lactate, and RPE (and qualitative inferences
for between-treatment differences) during the constant-load phase are summarized in Table 2.
Differences in steady-state responses between treatments were generally ‘unclear’, or small in
magnitude. The most consistent observation was that blood glucose levels tended to be slightly
higher in the trials containing carbohydrate (CHO and CP) versus other trials (PL and PRO).

Physiological Measurements during the Time-Trial
Physiological measurements obtained during the time trial are summarized, in addition to
qualitative inferences, in Table 3. Although there were some ‘unclear’ comparisons between
individual treatments, VO2, RER, blood glucose and lactate levels tended to be generally higher
in the CHO and CP trials versus the PL and PRO trials, which was likely a reflection of the
higher power outputs during the CHO and CP trials. RPE was similar across treatments.
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Figure 2. Comparison of mean time trial performance between experimental treatments.
Treatment effects (mean difference ± 90% CI) for each experimental beverage is compared to the
placebo. Open circles represent the mean value while the vertical lines represent the range of
individual values.
Probabilities of benefit/trivial/harm and Qualitative Inferences:
CHO-PL: ‘possible’ benefit (4/23/72) for CHO; PRO-PL: ‘unclear’ (10/48/92); CP-PL:
‘possible’ benefit (2/30/68) for CHO.
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Figure 3. Comparison of mean time trial performance between experimental treatments.
Treatment effects (mean difference ± 90% CI) for each experimental beverage is compared to the
carbohydrate-only beverage. Open circles represent the mean value while the vertical lines
represent the range of individual values.
Qualitative Inferences:
PRO-CHO: ‘unclear’ (51/36/13); CP-CHO: ‘unclear’ (39/36/25).
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Table 1. Constant Load Measurements.
Mean ± SD
Variable

Time

PL

CHO

PRO

Treatment Differences

CP

20

2548
± 515

2491
± 459

2455
± 424

2506
± 518

120

2681
± 509

2591
± 484

2624
± 564

2639
± 542

20

0.90
± 0.02

0.88
± 0.01

0.89
± 0.01

0.91
± 0.03

120

0.85
± 0.03

0.86
± 0.01

0.85
± 0.03

0.88
± 0.03

20

76 ± 11

80 ± 9

74 ± 5

81 ± 7

120

66 ± 7

75 ± 11

70 ± 5

75 ± 7

20

1.9
± 0.9

1.9
± 0.7

1.5
± 0.4

1.5
± 0.3

120

1.4
± 0.2

1.6
± 0.6

1.7
± 0.9

1.5
± 0.5

20

12.3
± 1.0

11.5
± 1.4

12.2
± 0.8

12.2
± 1.2

120

14.8
± 1.9

14.0
± 1.1

14.2
± 0.8

14.0
± 1.1

VO2
(ml·min-1)

RER

Glucose
(mg·dL-1)

Lactate
(mmol·L-1)

RPE
(6-20)

CHO-PL

PRO-PL

CP-PL

PRO-CHO

CP-CHO

-58 ± 120
3/70/27
Possible
-89 ± 128
3/44/53
Possible
-0.02 ± 0.02
3/3/94
Likely
0.01 ± 0.02
61/30/9
Unclear
-4 ± 9
51/29/20
Unclear
9 ± 11
80/8/12
Unclear
0.0 ± 0.8
45/23/32
Unclear
0.2 ± 0.5
84/6/10
Unclear
-0.8 ± 0.6
3/7/90
Likely
-0.8 ± 1.4
11/55/34
Unclear

14 ± 148
14/80/6
Unclear
61 ± 117
22/75/3
Likely Trivial
-0.02 ± 0.01
1/3/96
Very Likely
-0.01 ± 0.01
2/53/45
Possible
-5 ± 10
11/22/67
Unclear
2±4
70/26/4
Possible
-0.6 ± 1.0
11/12/77
Unclear
0.3 ± 0.7
56/9/35
Unclear
-0.4 ± 0.9
10/22/67
Unclear
0.0 ± 1.2
28/27/25
Unclear

-43 ± 115
4/65/31
Possible
-41 ± 158
7/52/41
Unclear
0.00 ± 0.02
33/29/38
Unclear
0.02 ± 0.02
90/7/3
Likely
5 ± 10
42/37/21
Unclear
10 ± 7
92/4/4
Likely
-0.4 ± 0.6
5/13/82
Unclear
0.1 ± 0.5
42/9/49
Unclear
-0.2 ± 0.6
17/32/51
Unclear
-0.8 ± 1.2
10/37/52
Unclear

77 ± 35
16/84/0
Likely Trivial
166 ± 182
76/23/1
Likely
0.01 ± 0.02
75/17/8
Unclear
-0.01 ± 0.02
5/17/78
Likely
-7 ± 5
1/4/95
Likely
-6 ± 12
15/12/73
Unclear
-0.6 ± 0.5
2/5/92
Likely
0.0 ± 1.0
31/7/62
Unclear
0.4 ± 1.1
66/19/15
Unclear
0.2 ± 1.4
42/38/21
Unclear

15 ± 77
5/89/6
Likely Trivial
48 ± 92
13/83/4
Likely Trivial
0.03 ± 0.02
88/5/6
Unclear
0.02 ± 0.02
74/19/7
Unclear
1±5
13/55/31
Unclear
1±6
43/29/28
Unclear
-0.4 ± 0.6
4/10/86
Likely
-0.1 ± 0.5
8/5/87
Unclear
0.7 ± 0.8
76/14/10
Unclear
0.0 ± 1.0
19/41/39
Unclear

*Note: One subject did not complete a PRO trial, so mean values (and corresponding treatment differences) were calculated on a
sample of 5

25

Table 2. Time Trial Measurements.
Variable

Mean ± SD

PL

CHO

PRO

Treatment Effects

CP

VO2
(ml·min-1)

2696
± 686

2729
± 726

2642
± 626

2959
± 867

RER

0.81
± 0.06

0.84
± 0.02

0.82
± 0.03

0.87
± 0.05

Glucose
(mg·dL-1)

63
±7

76
±6

66
±5

73
±6

Lactate
(mmol·L-1)

1.5
± 0.7

2.0
± 0.9

1.2
± 0.4

1.7
± 0.8

RPE
(6-20)

17.0
± 1.7

16.7
± 0.8

16.2
± 1.3

16.8
± 1.1

CHO-PL

PRO-PL

CP-PL

PRO-CHO

CP-CHO

34 ± 635
4/26/70
Possible
0.03 ± 0.04
63/30/6
Unclear
12.4 ± 3.3
100/0/0
Most Likely
0.5 ± 0.6
64/26/10
Unclear
-0.3 ± 0.8
20/64/16
Unclear

-93 ± 287
6/64/30
Unclear
-0.01 ± 0.03
4/40/56
Possible
0.0 ± 3.5
21/59/20
Unclear
-0.4 ± 0.9
13/15/72
Unclear
-0.4 ± 0.5
2/37/61
Possible

264 ± 480
14/77/10
Unclear
0.04 ± 0.01
100/0/0
Most Likely
9.8 ± 6.6
95/3/1
Very Likely
0.1 ± 0.6
9/37/54
Unclear
-0.2 ± 0.6
19/65/16
Unclear

154 ± 241
54/43/3
Possible
-0.03 ± 0.02
1/5/94
Likely
-11.1 ± 2.9
0/0/100
Most Likely
-0.7 ± 1.2
10/9/81
Unclear
-0.4 ± 0.5
2/33/65
Possible

230 ± 309
72/24/4
Possible
0.03 ± 0.03
69/24/7
Unclear
-2.7 ± 4.5
4/17/80
Likely
-0.4 ± 0.6
10/15/75
Unclear
0.2 ± 0.6
18/62/20
Unclear

*Note: One subject did not complete a PRO trial, so mean values (and corresponding treatment
differences) were calculated on a sample of 5.

GI Distress Symptoms
Ratings of GI discomfort were low across all treatments. Mean values (1-10 scale) measured
during the constant-load phase, and time-trial phase were ≤ 1.8 for all GI variables (stomach
problems, GI cramping, bloating, nausea, belching, and vomiting). No more than one subject per
treatment reported a score >2 at any particular time-point, and these ratings appeared to be
randomly distributed across treatments. No subject reported any GI symptoms greater than 5
(moderate).
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Chapter IV: Discussion
A primary purpose of the present study was to determine if the co-ingestion of
carbohydrate and protein during exercise enhanced cycling performance versus carbohydrate
alone. Performance in a 30 km time-trial (following 120 min at 55% Wmax) was ‘possibly’
improved by both CP (59.2 ± 9.4 min) and CHO (58.9 ± 6.5 min) versus a non-caloric placebo
(62.8 ± 8.1 min), but no clear differences were observed between CP and CHO beverages.
The observed improvement in cycling performance in our carbohydrate-containing
beverages (CHO and CP) has been reported in numerous prior studies (9, 14, 16). During
prolonged endurance exercise, the ergogenic effects of carbohydrate are largely attributed to the
maintenance of high rates of carbohydrate oxidation late in exercise (9, 12, 14, 16, 17, 20). In
support of this concept, we observed ‘likely’ elevations in steady-state RER and blood glucose
with CP supplementation when compared to the placebo. Additionally, CP co-ingested resulted
in ‘most likely’ and ‘very likely’ increases in time trial RER and blood glucose respectively, as
compared with the placebo.
Prior studies comparing the effects of CP and CHO on endurance performance have
provided conflicting findings. Some studies have reported relatively large improvements in
performance with CP (9, 14, 16), while others have shown no differences between CP and CHO
beverages (1, 12, 20, 21). Studies reporting no effects with CP have utilized beverages with high
carbohydrate content (60+ g/hr) and typically used time-trial protocols, suggesting that the
addition of protein may have little or no effects on time-trial performance when carbohydrate is
consumed at rates that maximize exogenous oxidation rates (1, 12, 21). The studies reporting
large improvements with CP have typically compared beverages containing moderate
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carbohydrate content (40-50 g/hr), and employed time-to-exhaustion protocols. Because no prior
studies have used a time-trial model to examine CP beverages containing moderate carbohydrate,
it is unclear whether protein can elicit benefits under these conditions. The current findings
provides novel information in this respect, as no clear improvements in time-trial performance
were observed with CP (45 gCHO/hr + 15 gPro/hr) versus CHO (45 g/hr).
It is not clear why CP with moderate carbohydrate could enhance time-to-exhaustion (9,
14, 16), but not performance in a long-duration time trial, as shown in the present study.
However, it is theoretically possible that the TTE protocol creates a more favorable environment
for detecting possible ergogenic effects with CP. For example, some evidence suggests that
carbohydrate and protein co-ingestion could shift carbohydrate usage towards exogenous blood
glucose potentially delaying the use of endogenous glycogen stores, which could contribute to a
delayed onset of fatigue (19). Similarly, there is indirect evidence that CP may impact endurance
performance via improved cardiovascular and thermoregulatory responses (4). It could be that
the prolonged moderate-intensity exercise of a TTE protocol could produce a metabolic
environment in which these factors contribute more directly to fatigue (versus a time trial), thus
increasing the likelihood that nutritional interventions, which impact these factors, would
produce favorable results. However, this is highly speculative, as the mechanisms responsible for
previously reported ergogenic effects with CP are poorly understood. In addition to the potential
physiological differences between protocols, Hopkins and colleagues reported that time trial
protocols may inherently introduce more error variance (due to differences in pacing), as
compared to TTE protocols (6). Therefore, it is possible that the TTE protocol might be more
sensitive in detecting small, but meaningful changes in performance compared to a TT protocol.
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There are also a few limitations in the existing study which could have impacted our
findings. The statistical power of our analyses was negatively affected by our small sample size,
as only five subjects completed all exercise protocols (with a sixth completing all but the PRO
trial). This decreases the confidence in our statistical conclusions. Furthermore, six additional
subjects dropped out of the study prior to completion, likely due to the large number of
demanding exercise trials (five three-hour trials over a month-long period, including the
familiarization trial). This raises the concern that our subjects may have had difficulty
maintaining consistent motivation and/or performance levels over the duration of the study. If so,
this would also increase error variance and minimize the likelihood of detecting meaningful
treatment effects. Therefore, further study is warranted in larger samples of competitive cyclists.
As indicated previously, the potential mechanisms to explain performance gains with CP
in prior studies (9, 14, 16) are not well understood. Some have suggested that ergogenic effects
are merely the result of additional calories from the supplemental protein (19, 20), while others
have suggested that protein may have synergistic effects with carbohydrate when co-ingested (9,
14, 16). Therefore, a second purpose of our study was to determine if protein ingestion (PRO)
alone affected cycling performance in comparison to a non-caloric placebo (PL). To our
knowledge, only one prior study has examined the potential ergogenic effects of protein
consumed in isolation. Schroer and colleagues (2014) reported that protein ingestion resulted in
possible performance impairments compared to placebo. However, these investigators utilized a
relatively high rate of protein ingestion (45 g/hr) in order to relate their findings to comparable
ingestion rates of carbohydrate. As a result, the possible impairments in performance with
protein could have been due to gastrointestinal distress related to malabsorption of the relatively
high doses of protein; a concept that was supported by increased incidents of GI discomfort with
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protein versus placebo. The present study was designed to examine a lower dose of protein
ingestion (15 g/hr), which is directly comparable to the supplemental doses of protein provided
in prior studies reporting ergogenic effects with CP co-ingestion (9, 14, 16). This rate of
ingestion was effective at minimizing gastrointestinal distress, as there was no evidence of
increased gastrointestinal symptoms with PRO, and symptoms were low across all trials.
However, PRO ingestion produced no clear benefits in performance (-0.6 ± 1.9 min) versus PL.
This provides additional evidence that protein ingestion in isolation has no ergogenic effects; and
thus, the previously reported benefits of CP beverages in some studies (9, 14, 16) were possibly
the result of synergistic effects with carbohydrate. However, as mentioned previously, these
conclusions should be interpreted cautiously due to the low statistical power in the present study.
In summary, co-ingestion of carbohydrate and protein at moderate intake rates (45
gCHO/hr + 15 gPro/hr) had no effect on cycling time-trial performance versus carbohydrate
alone (45 g/hr). In addition, protein intake alone (15 g/hr) had no ergogenic effects versus a noncaloric placebo. However, further study of this topic is required, as the present study lacked the
statistical power to detect small but athletically-relevant differences in performance between
treatments.
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